Greek Doctor Uses AI To Improve Life Of Cancer Patients

Dr. Peter Metrakos is the Greek leader of a research team that uses breakthrough artificial intelligence (AI) technology to improve the survival rates of cancer patients. 

Based in Canada, the team of physicians are working to help patients with colorectal cancer survive this shockingly deadly disease, which currently has a five-year survival rate of just 12%.

The research team is working with the Research Institute of the McGill University Health Centre (RI-MUHC) to develop personalized medicine in the colorectal cancer field and the whole project is based on Metrakos’ 2016 research into colorectal cancer cells’ relationship to blood vessels.

The Greek doctor and his team will use liquid biopsy methods to isolate the constituent sections of a cancer patient's blood in order to figure out which ones are linked to the disease. This information will be given anonymously to MIM, a Montreal-based AI company, which will attempt to identify patterns in patients' blood.

Using the data obtained through AI, researchers should be able to create customized treatment plans for patients who would otherwise not respond to conventional therapies.